Multi-device Testing for Autonomic Nervous System Stimulation

April 14, 2020 updated by: yilong Wang, Beijing Tiantan Hospital

The Vagus nerve (VN) serve as an "unconscious inner brain" that integrates messages from the body and provides metabolic homeostatic regulation to various organs.In this study the investigators want to compare different ways to stimulate the vagus nerve to assess their respective effects compared to a sham stimulation.

Each participant will be exposed in a random way to 7 different ways to stimulate the VN:

  • Manual Head Massage
  • Mechanical Head Massager (BREO Inc. Helmet)
  • Low laser Therapy (LLT)
  • Sham LLT
  • Transcutaneous Electrical Nervous Stimulation (TENS) ear stimulation (as testing phase prototype device)
  • Deep and slow breathing (as testing intervention based on video app)
  • Relaxed reading time (as control situation)

Therefore, within the same design the investigators want to conduct two separate studies that should lead to two separate publications:

  • Study 1: comparison of manual head massage to mechanical Helmet massager and relaxed reading
  • Study 2: comparison of LLT with sham LLT and relaxed reading

The two other interventions: TENS ear stimulation and Deep and Slow breathing are purely observational to gain knowledge in context of a convenient design.

Study Overview

Detailed Description

OBJECTIVES Overall objective is to assess the respective effects of the different ways to stimulate the Vagus Nerve on the Heart Rate Variability (HRV) parameters: High Frequency (HF), Low Frequency (LF), Total Power (TP), Heart rate (HR), and blood pressure (BP).

Specific objectives:

  • Comparison of Manual Head Massage to Mechanical Head Massager to Control situation
  • Comparison of Low Laser Therapy (LLT) to sham LLT to control situation
  • Effects of TENS ear stimulation (descriptive)
  • Effects of Deep and Slow breathing (descriptive)

Study Type

Interventional

Enrollment (Actual)

15

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Beijing, China
        • Center for Autonomic Evaluation and Brain Plasticity Advanced Innovation Center for Human Brain Protection

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

20 years to 40 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Healthy volunteers aged 20 to 40 in normal context

Exclusion Criteria:

  • To have work night shift the night before
  • To use certain drugs that affect the ANS (beta blockers, beta stimulant, hypnotic, for instance)
  • To be in situation of unusual life stress
  • To have a chronic disease that require some daily treatment
  • Not to stay in Beijing for the duration of the investigation

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Head massage by therapist
Head massage therapist will practice massage covering the scalp, front head, occipital area and neck.
Duration 10 minutes.
Active Comparator: Helmet massage BREO
Breo helmet will be installed for massaging the head at different defined places.
Duration 10 minutes.
Active Comparator: Low Laser Therapy
Laser light can penetrate the skin and stimulate the nervous connections. The investigators will use a laser pen (Min Sheng).
Duration 7 minutes.
Active Comparator: Sham Low Laser Therapy
The investigators will use the same laser pen, but without laser beam.
Duration 7 minutes.
Active Comparator: TENS ear stimulation
The investigators will use the (Hwato) device that provides electrical pulse at various frequency and intensity. This TENS device is a prototype modified for ear stimulation.
Duration 7 minutes.
Active Comparator: Deep and Slow breathing
This intervention is guided by an app that leads to a full respiratory.
A full respiratory cycle of 10 seconds with 5 seconds for inspiration and 5 seconds for expiration.
Sham Comparator: Relaxed Reading time
Participants will read the newspaper in a quiet environment.
Duration 10 minutes.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Changes of HRV recording parameters
Time Frame: Changes from baseline HRV parameters at post intervention 15 minutes
The investigators will use the BIOPAC Machine that captures ECG data, signals were sampled at 500 Hz throughout the testing. Recorded data were reviewed and analyzed using AcqKnowledge software version 4.2. The HRV recording parameters include: (1) Very Low Frequency (VLF) (< 0.04 Hz), (2) Low Frequency (LF) (0.04 - 0.15 Hz), (3) High Frequency (HF) (0.15 to 0.4 Hz), (4) Total Power (TP), which was calculated by summing up all frequency bands, (5) Total Power partial (TPp) (HF + LF), (6) HFnu (normalized unit of HF), (7) Ratio (HF divided by LF).
Changes from baseline HRV parameters at post intervention 15 minutes

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change of Blood Pressure (Systolic and Diastolic Blood pressure)
Time Frame: Change from baseline systolic and diastolic blood pressure at post intervention 15 minutes
Both systolic and diastolic blood pressure will be recorded by an automated monitoring device (OMROM - HEM 7124) at baseline (after the 5 minutes rest) and at the end of the 15 minutes follow-up.
Change from baseline systolic and diastolic blood pressure at post intervention 15 minutes
Change of Heart Rate
Time Frame: Change from baseline heart rate at post intervention 15 minutes
Heart rate will be monitored at the same time of blood pressure
Change from baseline heart rate at post intervention 15 minutes
Change of Body Tension
Time Frame: Change from baseline body tension at post intervention 15 minutes
Body tension is assessed using a a 10-point Likert-scale (the minimum score is 0, and the maximum score is 10)ratings of perceived body tension (BT) as indicator of stress. The highers scores indicate more stress.
Change from baseline body tension at post intervention 15 minutes

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Collet Jean-Paul, MD, Phd, Advanced Innovation Center for Human Brain Protection

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 1, 2019

Primary Completion (Actual)

March 23, 2020

Study Completion (Actual)

March 24, 2020

Study Registration Dates

First Submitted

March 25, 2020

First Submitted That Met QC Criteria

April 7, 2020

First Posted (Actual)

April 10, 2020

Study Record Updates

Last Update Posted (Actual)

April 15, 2020

Last Update Submitted That Met QC Criteria

April 14, 2020

Last Verified

April 1, 2020

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

Yes

IPD Plan Description

Need to contact the PI (Dr Collet). Dataset will be transferred with respect of the privacy and confidentiality

IPD Sharing Time Frame

About one month

IPD Sharing Access Criteria

Demand from one academic center

IPD Sharing Supporting Information Type

  • Study Protocol

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Vagus Nerve Stimulation

Clinical Trials on Manual Head Massage

Subscribe